Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.

New therapeutics to combat malaria are desperately needed. Here we show that the enzyme protein farnesyltransferase (PFT) from the malaria parasite Plasmodium falciparum (P. falciparum) is an ideal drug target. PFT inhibitors (PFTIs) are well tolerated in man, but are highly cytotoxic to P. falciparum. Because of their anticancer properties, PFTIs comprise a highly developed class of compounds. PFTIs are ideal for the rapid development of antimalarials, allowing "piggy-backing" on previously garnered information. Low nanomolar concentrations of tetrahydroquinoline (THQ)-based PFTIs inhibit P. falciparum PFT and are cytotoxic to cultured parasites. Biochemical studies suggest inhibition of parasite PFT as the mode of THQ cytotoxicity. Studies with malaria-infected mice show that THQ PFTIs dramatically reduce parasitemia and lead to parasite eradication in the majority of animals. These studies validate P. falciparum PFT as a target for the development of antimalarials and describe a potent new class of THQ PFTIs with antimalaria activity.

[1]  S. Chong,et al.  Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity. , 2000, Journal of medicinal chemistry.

[2]  Christian Scheurer,et al.  Identification of an antimalarial synthetic trioxolane drug development candidate , 2004, Nature.

[3]  E. Corey,et al.  Formation of olefins via pyrolysis of sulfonate esters , 1989 .

[4]  C. Bowden,et al.  Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro. , 2001, Cancer research.

[5]  C. Lambros,et al.  Synchronization of Plasmodium falciparum erythrocytic stages in culture. , 1979, The Journal of parasitology.

[6]  P. Muller,et al.  Synthesis Routes Towards the Farnesyl Protein Transferase Inhibitor ZARNESTRATM , 2004 .

[7]  D M Leonard,et al.  Ras farnesyltransferase: a new therapeutic target. , 1997, Journal of medicinal chemistry.

[8]  S. Sebti,et al.  Inhibitors of protein farnesyltransferase as novel anticancer agents. , 2002, Current topics in medicinal chemistry.

[9]  D. Chakrabarti,et al.  Protein prenyl transferase activities of Plasmodium falciparum. , 1998, Molecular and biochemical parasitology.

[10]  P. Rathod,et al.  Resistance to a Protein Farnesyltransferase Inhibitor in Plasmodium falciparum* , 2005, Journal of Biological Chemistry.

[11]  C. Baum,et al.  Sch-66336 (sarasar) and other benzocycloheptapyridyl farnesyl protein transferase inhibitors: discovery, biology and clinical observations. , 2003, Current topics in medicinal chemistry.

[12]  G. Klebe,et al.  Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo. , 2004, Angewandte Chemie.

[13]  V. Stoll,et al.  Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potency. , 2003, Bioorganic & medicinal chemistry letters.

[14]  D. Chakrabarti,et al.  In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability. , 2004, Bioorganic & medicinal chemistry.

[15]  M. Gelb,et al.  Differential Prenyl Pyrophosphate Binding to Mammalian Protein Geranylgeranyltransferase-I and Protein Farnesyltransferase and Its Consequence on the Specificity of Protein Prenylation* , 1997, The Journal of Biological Chemistry.

[16]  S. Sebti,et al.  Farnesyltransferase Inhibitors in Cancer Therapy , 2000 .

[17]  S. Croft,et al.  Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents. , 2004, Journal of medicinal chemistry.

[18]  D. Chakrabarti,et al.  Protein Farnesyltransferase and Protein Prenylation inPlasmodium falciparum * , 2002, The Journal of Biological Chemistry.

[19]  W. Trager,et al.  Human malaria parasites in continuous culture. , 1976, Science.

[20]  Wim G J Hol,et al.  Drugs to Combat Tropical Protozoan Parasites , 2002, Science.

[21]  Protein prenyltransferases : Isoprenoids - Biosynthesis and role in the regulation of protein function , 1992 .

[22]  A. D. Rodrigues,et al.  Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency. , 2001, Journal of medicinal chemistry.

[23]  C. Der,et al.  Ras Family Signaling: Therapeutic Targeting , 2002, Cancer biology & therapy.

[24]  J. Tokarski,et al.  Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors. , 2005, Bioorganic & medicinal chemistry letters.